Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro
- 1 June 1981
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 20 (1), 39-46
- https://doi.org/10.1007/bf00554665
Abstract
The effects of liver disease and environmental factors on hepatic microsomal cytochrome P-450 content, NADPH-cytochrome c reductase (reductase) activity and aryl hydrocarbon hydroxylase (AHH) activity have been simultaneously investigated in 70 patients undergoing diagnostic liver biopsy. The activity of reductase was not significantly affected by the presence of liver disease or any of the environmental factors studied. Cytochrome P-450 content decreased with increasing severity of liver disease whereas AHH activity was only significantly reduced in biopsies showing hepatocellular destruction. None of the parameters of monooxygenase activity varied significantly with the age or sex of the patients. Alcohol excess was associated with decreased cytochrome P-450 content and AHH activity and this effect was independent of the histological status of the biopsy. Both high caffeine intake and cigarette smoking increased AHH activity in the absence of any change in cytochrome P-450 content. There was a positive correlation between the number of meat meals eaten per week and cytochrome P-450 content. Chronic treatment with enzyme-inducing anticonvulsants appeared to increase both cytochrome P-450 content and AHH activity. Despite differential effects of liver disease and environmental influences on cytochrome P-450 content and AHH activity there was a highly significant correlation between the two parameters. The results of the present study correlate well with the known effects of disease and environment on drug metabolism in vivo.Keywords
This publication has 37 references indexed in Scilit:
- Monooxygenase enzyme activity in alcoholics with varying degrees of liver damage.Gut, 1979
- Drug metabolism in malnourished children: a study with antipyrine.Archives of Disease in Childhood, 1979
- Contribution of Environmental Factors to Variability in Human Drug MetabolismDrug Metabolism Reviews, 1979
- Drug Kinetics and Alcohol IngestionClinical Pharmacokinetics, 1978
- Metabolites of benzo(a) pyrene produced by placental microsomes from cigarette smokers and nonsmokersLife Sciences, 1977
- Amylobarbitone Hydroxylation Kinetics in Small Samples of Rat and Human LiverXenobiotica, 1976
- Drug Disposition and Liver DiseaseDrug Metabolism Reviews, 1975
- Properties of Benzpyrene Hydroxylase from Human Liver and Comparison with the Rat, Rabbit and Guinea-pig EnzymesXenobiotica, 1975
- The metabolism of [UREYL-14C] tolbutamide in vitro and invivo in manLife Sciences, 1973
- MECHANISM OF HEPATIC DRUG OXIDATION AND ITS RELATIONSHIP TO INDIVIDUAL DIFFERENCES IN RATES OF OXIDATION IN MAN*Annals of the New York Academy of Sciences, 1971